The challenge of developing robust drugs to overcome resistance

被引：18
|
作者：
Anderson, Amy C. [1 ,2 ]
Pollastri, Michael P. [1 ,3 ]
Schiffer, Celia A. [1 ,4 ]
Peet, Norton P. [1 ,5 ]
机构：
[1] Univ Massachusetts, Sch Med, Inst Drug Resistance, Worcester, MA 01605 USA
[2] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA
[3] Northeastern Univ, Dept Chem & Chem Biol, Egan Res Ctr 417, Boston, MA 02115 USA
[4] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA
[5] Microbiotix Inc, Worcester, MA 01605 USA
来源：
DRUG DISCOVERY TODAY | 2011年 / 16卷 / 17-18期
关键词：
HIV-1 PROTEASE INHIBITORS; AUREUS DIHYDROFOLATE-REDUCTASE; SUBSTRATE-ENVELOPE HYPOTHESIS; TYROSINE KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; CELL LUNG-CANCER; STAPHYLOCOCCUS-AUREUS; DNA GYRASE; BCR-ABL; ESCHERICHIA-COLI;
D O I：
10.1016/j.drudis.2011.07.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Drug resistance is problematic in microbial disease, viral disease and cancer. Understanding at the outset that resistance will impact the effectiveness of any new drug that is developed for these disease categories is imperative. In this Feature, we detail approaches that have been taken with selected drug targets to reduce the susceptibility of new drugs to resistance mechanisms. We will also define the concepts of robust drugs and resilient targets, and discuss how the design of robust drugs and the selection of resilient targets can lead to successful strategies for combating resistance.
引用
收藏
页码：755 / 761
页数：7
相关论文
共 50 条
  • [1] Enhancing pharmacists' role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review
    Sakeena, M. H. F.
    Bennett, Alexandra A.
    McLachlan, Andrew J.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2018, 7
  • [2] Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review
    M. H. F. Sakeena
    Alexandra A. Bennett
    Andrew J. McLachlan
    Antimicrobial Resistance & Infection Control, 7
  • [3] Acquired resistance to targeted drugs and novel therapy to overcome the resistance
    Yano, Seiji
    ANNALS OF ONCOLOGY, 2017, 28 : 70 - 70
  • [4] Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia
    Scoffone, Viola C.
    Barbieri, Giulia
    Buroni, Silvia
    Scarselli, Maria
    Pizza, Mariagrazia
    Rappuoli, Rino
    Riccardi, Giovanna
    TRENDS IN MICROBIOLOGY, 2020, 28 (04) : 315 - 326
  • [5] COLOMATE challenge to overcome resistance in metastatic colorectal cancer
    Yoshino, Takayuki
    ONCOLOGY-NEW YORK, 2021, 35 (10): : 656 - 657
  • [6] Combining Allosteric and Orthosteric Drugs to Overcome Drug Resistance
    Ni, Duan
    Li, Yun
    Qiu, Yuran
    Pu, Jun
    Lu, Shaoyong
    Zhang, Jian
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (05) : 336 - 348
  • [7] Drugs join forces to overcome lung cancer resistance
    不详
    CANCER BIOLOGY & THERAPY, 2009, 8 (22) : VII - VII
  • [8] Platinum drugs and taxanes: can we overcome resistance?
    Elena V. Sazonova
    Gelina S. Kopeina
    Evgeny N. Imyanitov
    Boris Zhivotovsky
    Cell Death Discovery, 7
  • [9] Platinum drugs and taxanes: can we overcome resistance?
    Sazonova, Elena V.
    Kopeina, Gelina S.
    Imyanitov, Evgeny N.
    Zhivotovsky, Boris
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [10] Long-acting HIV drugs advanced to overcome adherence challenge
    Elie Dolgin
    Nature Medicine, 2014, 20 : 323 - 324
12345